Cargando…
Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by TP53 p.R337H Carriers
Breast cancer (BC) is the most prevalent malignancy in women with Li-Fraumeni syndrome (LFS). The literature on BC in LFS is limited due to its rarity worldwide. A TP53 founder pathogenic variant (c.1010G>A; p.R337H) is responsible for the higher prevalence of this syndrome among women of Brazili...
Autores principales: | Sandoval, Renata Lazari, Polidorio, Natalia, Leite, Ana Carolina Rathsam, Cartaxo, Mariana, Pisani, Janina Pontes, Quirino, Carla Vanessa, Cezana, Loureno, Pereira, Natálya Gonçalves, Pereira, Allan Andresson Lima, Rossi, Benedito Mauro, Achatz, Maria Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966034/ https://www.ncbi.nlm.nih.gov/pubmed/35371985 http://dx.doi.org/10.3389/fonc.2022.836937 |
Ejemplares similares
-
Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome
por: Sandoval, Renata Lazari, et al.
Publicado: (2021) -
Cancer surveillance for patients with Li-Fraumeni Syndrome in Brazil: A cost-effectiveness analysis
por: Frankenthal, Isadora A., et al.
Publicado: (2022) -
Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil
por: Giacomazzi, Juliana, et al.
Publicado: (2014) -
The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations
por: Silva, Amanda G, et al.
Publicado: (2014) -
Occurrence of Neuroblastoma among TP53 p.R337H Carriers
por: Seidinger, Ana Luiza, et al.
Publicado: (2015)